Overview

Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA)

Status:
Recruiting
Trial end date:
2023-05-30
Target enrollment:
Participant gender:
Summary
multi-center, randomized, double-blind, placebo-controlled, dose-finding, 4-arm, parallel assignment study to evaluate the efficacy of three different doses of sulthiame (STM) compared to placebo on sleep apnea activity in adult patients with obstructive sleep apnea.
Phase:
Phase 2
Details
Lead Sponsor:
Desitin Arzneimittel GmbH
Treatments:
Sulthiame